Methylated SEPTIN9 plasma test for colorectal cancer detection may be applicable to Lynch syndrome

OBJECTIVE: The plasma-based methylated SEPTIN9 (mSEPT9) is a colorectal cancer (CRC) screening test for adults aged 50–75 years who are at average risk for CRC and have refused colonoscopy or faecal-based screening tests. The applicability of mSEPT9 for high-risk persons with Lynch syndrome (LS), th...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMJ Open Gastroenterol
Autors principals: Hitchins, Megan P, Vogelaar, Ingrid P, Brennan, Kevin, Haraldsdottir, Sigurdis, Zhou, Nianmin, Martin, Brock, Alvarez, Rocio, Yuan, Xiaopu, Kim, Sungjin, Guindi, Maha, Hendifar, Andrew E, Kalady, Matthew F, DeVecchio, Jennifer, Church, James M, de la Chapelle, Albert, Hampel, Heather, Pearlman, Rachel, Christensen, Maria, Snyder, Carrie, Lanspa, Stephen J, Haile, Robert W, Lynch, Henry T
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2019
Matèries:
Colorectal Cancer
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6577308/
https://ncbi.nlm.nih.gov/pubmed/31275589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjgast-2019-000299
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars